APP and Alzheimer disease: Aged APP/PSEN double transgenic mice are well adopted for AD research because they possess a broad range of behavioral and pathological AD-like phenotypes, such as cognitive and noncognitive deficits, as well as the accumulation of amyloid plaques [16].